McKesson Corp. (NYSE:MCK), a diversified healthcare stock, will sell its Rexall pharmacy and Well.ca online retail businesses to Birch Hill Equity Partners, a Canadian private equity firm ...

Over the past 13 years, Baltimore spent at least $197 million — an average of more than $15 million a year — combating the raging opioid epidemic, an expert hired by the city testified in its civil ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

A Drug Enforcement Administration agent in October 2005 requested documents about drug distributor McKesson’s sale of opioids to an internet pharmacy in East Baltimore. In a March 2009 email to ...

Big pharmacies like Drug City ordered large quantities of opioids, he agreed, but they also bought large quantities of other ...

McKesson launches InspiroGene by McKesson, a dedicated business focused solely on supporting the commercialization of cell ...

McKesson and Cabinet’s partnership leads ... to partner with the organization which continues to be a prominent pharmacy partner. Knox - In the realm of direct-to-consumer businesses, where ...

Shares of McKesson (MCK) are oversold. They are also at a potential support level. Stocks that are oversold and at support tend to rally. The best traders traders focus on key price levels and ...

Robert W. Baird analyst Eric Coldwell downgraded the rating on McKesson (MCK – Research Report) to a Hold today, setting a price target of $531.00. Eric Coldwell’s rating is based on a series ...

McKesson (MCK) closed at $488.78 in the latest trading session, marking a -1.95% move from the prior day. This change lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw an upswing of ...